Sign In
Buy DHR
$178.08
+1.97 (+1.12%)
At Close: Jun 03, 2026
Danaher to Benefit From Business Strength Amid Headwinds
10:20am, Friday, 11'th Oct 2024
DHR stands to benefit from strength in the clinical diagnostics business, Abcam buyout and shareholder-friendly policies. Softness in the Instrument unit remains a concern.
3 Dividend Titans With Pricing Power Straight From The Hedge Fund Playbook
07:30am, Tuesday, 01'st Oct 2024
Learning from successful hedge funds like Millennium means focusing on minimizing risks. To achieve this, I focus on companies with strong pricing power. They have wide moats and recurring revenue tha
Danaher Q3 Preview: Market Share Gains In Molecular Testing
04:19am, Wednesday, 25'th Sep 2024
I reiterate my 'Strong Buy' rating for Danaher, with a one-year price target of $310 per share, citing recovery in bioprocessing and market share gains in molecular testing. Danaher's bioprocessing ma
Dublin, Sept. 24, 2024 (GLOBE NEWSWIRE) -- The "Global Automated and Closed Cell Therapy Market 2024-2029" report has been added to ResearchAndMarkets.com's offering.
The Ultimate 5: My Highest-Conviction Dividend Stocks
07:30am, Tuesday, 24'th Sep 2024
I explore the idea of managing a highly concentrated portfolio and share how I narrowed down my highest-conviction dividend investments to just five stocks. I emphasize the importance of choosing reli
Danaher Schedules Third Quarter 2024 Earnings Conference Call
04:30pm, Thursday, 19'th Sep 2024
WASHINGTON , Sept. 19, 2024 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that it will webcast its quarterly earnings conference call for the third quarter 2024 on Tuesday, October 22, 20
The Big 3: ANET, MET, DHR
12:26pm, Thursday, 19'th Sep 2024
Today's Big 3 looks at companies trading at or near their 52-week highs but show very different long-term charts. Dan Deming joins Diane King Hall and Ben Lichtenstein to break down the technical tren
Beckman Coulter and Scopio Labs Add World's First Digital Bone Marrow Imaging and Analysis to Long-Term Partnership
08:30am, Tuesday, 17'th Sep 2024
BREA, Calif. and TEL AVIV, Israel , Sept.
Danaher Announces Quarterly Dividend
04:15pm, Tuesday, 10'th Sep 2024
WASHINGTON , Sept. 10, 2024 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced today that its Board of Directors has approved a regular quarterly cash dividend of $0.27 per share of its common
Here's Why It is Appropriate to Retain Danaher Stock For Now
01:01pm, Tuesday, 10'th Sep 2024
DHR benefits from solid momentum across its Diagnostics segment. However, increasing expenses remain a concern.
Danaher Confirms Third Quarter and Full Year 2024 Guidance
04:30pm, Wednesday, 04'th Sep 2024
WASHINGTON , Sept. 4, 2024 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) (the "Company") confirmed its previously issued guidance for the third quarter and full year 2024 ahead of a previously sched
HTHIY or DHR: Which Is the Better Value Stock Right Now?
12:41pm, Tuesday, 27'th Aug 2024
Investors with an interest in Diversified Operations stocks have likely encountered both Hitachi Ltd. (HTHIY) and Danaher (DHR).
Danaher to Webcast Diagnostics Investor & Analyst Meeting in Washington, D.C.
05:30pm, Monday, 26'th Aug 2024
WASHINGTON , Aug. 26, 2024 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) will host a live video webcast of its Diagnostics Investor and Analyst Meeting in Washington, D.C. on September 5, 2024 begi
Danaher: Lofty Price, Bright Future
01:06pm, Thursday, 22'nd Aug 2024
Danaher's high valuation and flat 2024 EPS growth might raise eyebrows, but its track record, strategic acquisitions, and long-term growth potential make it a solid buy for those who can. Despite trad
Why Is Danaher (DHR) Up 2% Since Last Earnings Report?
12:36pm, Thursday, 22'nd Aug 2024
Danaher (DHR) reported earnings 30 days ago. What's next for the stock?
